Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

A RECENT investigation carried out in this laboratory revealed that rats treated with glucagon gained less weight and contained much less fat, protein and water than pair-fed controls. Since the ...